+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Philippines Diabetes Care Devices Market Report and Forecast 2024-2032

  • PDF Icon

    Report

  • 160 Pages
  • February 2024
  • Region: Philippines
  • Expert Market Research
  • ID: 5941039

Philippines Diabetes Care Devices Market Outlook

The Philippines diabetes care devices market size is anticipated to grow at a CAGR of 7.6 % during the forecast period of 2024-2032, driven increasing incidence of diabetes among the population and awareness initiatives to detect the condition early.

Diabetes Care Devices: Introduction

Diabetes care devices are tools designed to monitor and manage blood glucose levels in individuals with diabetes. These include blood glucose meters, continuous glucose monitoring (CGM) systems, insulin pumps, and insulin pens. Blood glucose meters provide instant readings, while CGM systems offer real-time glucose level tracking. Insulin pumps and pens assist in precise insulin delivery, enhancing glycemic control. These devices are crucial for preventing diabetes-related complications by enabling patients to maintain optimal blood glucose levels through self-management and continuous monitoring.

Key Trends in the Philippines Diabetes Care Devices Market

The increasing incidence of diabetes among the population is driving demand for diabetes care devices. Lifestyle factors and rising obesity rates contribute to this trend, necessitating enhanced diabetes management solutions.

There's a growing awareness of diabetes and its management among Filipinos. Government and non-government organizations are conducting educational campaigns to promote understanding of diabetes care, leading to higher demand for monitoring and insulin delivery devices.

The adoption of advanced diabetes care devices, such as continuous glucose monitoring (CGM) systems and insulin pumps, is on the rise. Patients are increasingly seeking out devices that offer convenience, accuracy, and minimal invasiveness.

Efforts to improve healthcare infrastructure and access in the Philippines are positively impacting the diabetes care devices market. Increased healthcare spending and expansion of healthcare services across the country make diabetes care devices more accessible to patients.

Despite market growth, challenges remain in terms of accessibility and affordability of diabetes care devices for a significant portion of the population. High costs and limited insurance coverage for advanced devices restrict their widespread adoption.

There's an emerging trend of integrating digital health solutions and mobile applications with diabetes care devices. These tools help patients better manage their condition through real-time data tracking, analysis, and personalized insights.

Philippines Diabetes Care Devices Market Segmentation

Market Breakup by Type

  • Monitoring Devices
  • Self-monitoring Blood Glucose Devices
  • Glucometer Devices
  • Test Strips
  • Lancets
  • Continuous Blood Glucose Monitoring
  • Sensors
  • Durables

Market Breakup by Management Devices

  • Insulin Pump
  • Insulin Pump Device
  • Insulin Pump Reservoir
  • Infusion Set
  • Insulin Syringes
  • Insulin Cartridges
  • Disposable Pens

Market Breakup by End User

  • Hospitals and Clinics
  • Homecare Settings
  • Diagnostic Centres

Market Breakup by Distribution Channel

  • Retail Pharmacies
  • Online Pharmacies
  • Diabetes Clinics and Centres

Philippines Diabetes Care Devices Market Overview

In the Philippines, the diabetes care devices market is experiencing significant growth driven by an increasing diabetes prevalence and a growing awareness of effective disease management. The demand for both blood glucose monitoring devices and insulin delivery systems is rising, reflecting a shift towards more proactive and self-managed diabetes care. Technological advancements, such as continuous glucose monitoring (CGM) systems, are gaining traction, albeit affordability and accessibility remain challenges for a broader population. Efforts to enhance healthcare infrastructure and government initiatives to improve diabetes care accessibility are key factors shaping market dynamics. Additionally, there's a trend towards integrating digital health solutions to support diabetes management, offering potential for further market development.

Philippines Diabetes Care Devices Market: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players.
  • Becton and Dickenson
  • Medtronic
  • Insulet
  • Tandem
  • Ypsomed
  • Novo Nordisk
  • Sanofi
  • Eli Lilly
  • Abbott
  • Roche
  • Lifescan (Johnson & Johnson)
  • Dexcom


This product will be delivered within 5-7 business days.

Table of Contents

1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Philippines Diabetes Care Devices Market Overview
3.1 Philippines Diabetes Care Devices Market Historical Value (2017-2023)
3.2 Philippines Diabetes Care Devices Market Forecast Value (2024-2032)
4 Philippines Diabetes Care Devices Market Dynamics
4.1 Market Drivers and Constraints
4.2 SWOT Analysis
4.2.1 Strengths
4.2.2 Weaknesses
4.2.3 Opportunities
4.2.4 Threats
4.3 Porter’s Five Forces Model
4.3.1 Bargaining Power of Suppliers
4.3.2 Bargaining Power of Buyers
4.3.3 Threat of New Entrants
4.3.4 Threat of Substitutes
4.3.5 Degree of Rivalry
4.4 Key Demand Indicators
4.5 Key Price Indicators
4.6 Industry Events, Initiatives, and Trends
4.7 Value Chain Analysis
5 Philippines Diabetes Care Devices Market Segmentation
5.1 Philippines Diabetes Care Devices Market by Type
5.1.1 Market Overview
5.1.2 Monitoring Devices
5.1.2.1 Self-monitoring Blood Glucose Devices
5.1.2.1.1 Glucometer Devices
5.1.2.1.2 Test Strips
5.1.2.1.3 Lancets
5.1.2.2 Continuous Blood Glucose Monitoring
5.1.2.2.1 Sensors
5.1.2.2.2 Durables
5.2 Philippines Diabetes Care Devices Market by Management Devices
5.2.1 Insulin Pump
5.2.1.1 Insulin Pump Device
5.2.1.2 Insulin Pump Reservoir
5.2.1.3 Infusion Set
5.2.2 Insulin Syringes
5.2.3 Insulin Cartridges
5.2.4 Disposable Pens
5.3 Philippines Diabetes Care Devices Market by End User
5.3.1 Market Overview
5.3.2 Hospitals and Clinics
5.3.3 Homecare Settings
5.3.4 Diagnostic Centres
5.4 Philippines Diabetes Care Devices Market by Distribution Channel
5.4.1 Market Overview
5.4.2 Retail Pharmacies
5.4.3 Online Pharmacies
5.4.4 Diabetes Clinics and Centres
6 Patent Analysis
6.1 Analysis by Type of Patent
6.2 Analysis by Publication Year
6.3 Analysis by Issuing Authority
6.4 Analysis by Patent Age
6.5 Analysis by CPC Analysis
6.6 Analysis by Patent Valuation
6.7 Analysis by Key Players
7 Grants Analysis
7.1 Analysis by Year
7.2 Analysis by Amount Awarded
7.3 Analysis by Issuing Authority
7.4 Analysis by Grant Application
7.5 Analysis by Funding Institute
7.6 Analysis by NIH Departments
7.7 Analysis by Recipient Organization
8 Funding Analysis
8.1 Analysis by Funding Instances
8.2 Analysis by Type of Funding
8.3 Analysis by Funding Amount
8.4 Analysis by Leading Players
8.5 Analysis by Leading Investors
8.6 Analysis by Geography
9 Partnership and Collaborations Analysis
9.1 Analysis by Partnership Instances
9.2 Analysis by Type of Partnership
9.3 Analysis by Leading Players
9.4 Analysis by Geography
10 Regulatory Framework
10.1 Regulatory Overview
11 Supplier Landscape
11.1 Becton and Dickenson
11.1.1 Financial Analysis
11.1.2 Product Portfolio
11.1.3 Demographic Reach and Achievements
11.1.4 Mergers and Acquisitions
11.1.5 Certifications
11.2 Medtronic
11.2.1 Financial Analysis
11.2.2 Product Portfolio
11.2.3 Demographic Reach and Achievements
11.2.4 Mergers and Acquisitions
11.2.5 Certifications
11.3 Insulet
11.3.1 Financial Analysis
11.3.2 Product Portfolio
11.3.3 Demographic Reach and Achievements
11.3.4 Mergers and Acquisitions
11.3.5 Certifications
11.4 Tandem
11.4.1 Financial Analysis
11.4.2 Financial Portfolio
11.4.3 Demographic Reach and Achievements
11.4.4 Mergers and Acquisitions
11.4.5 Certifications
11.5 Ypsomed
11.5.1 Financial Analysis
11.5.2 Product Portfolio
11.5.3 Demographic Reach and Achievements
11.5.4 Mergers and Acquisitions
11.5.5 Certifications
11.6 Novo Nordisk
11.6.1 Financial Analysis
11.6.2 Product Portfolio
11.6.3 Demographic Reach and Achievements
11.6.4 Mergers and Acquisitions
11.6.5 Certifications
11.7 Sanofi
11.7.1 Financial Analysis
11.7.2 Product Portfolio
11.7.3 Demographic Reach and Achievements
11.7.4 Mergers and Acquisitions
11.7.5 Certifications
11.8 Eli Lilly
11.8.1 Financial Analysis
11.8.2 Product Portfolio
11.8.3 Demographic Reach and Achievements
11.8.4 Mergers and Acquisitions
11.8.5 Certifications
11.9 Abbott
11.9.1 Financial Analysis
11.9.2 Product Portfolio
11.9.3 Demographic Reach and Achievements
11.9.4 Mergers and Acquisitions
11.9.5 Certifications
11.10 Roche
11.10.1 Financial Analysis
11.10.2 Product Portfolio
11.10.3 Demographic Reach and Achievements
11.10.4 Mergers and Acquisitions
11.10.5 Certifications
11.11 Lifescan (Johnson & Johnson)
11.11.1 Financial Analysis
11.11.2 Product Portfolio
11.11.3 Demographic Reach and Achievements
11.11.4 Mergers and Acquisitions
11.11.5 Certifications
11.12 Dexcom
11.12.1 Financial Analysis
11.12.2 Product Portfolio
11.12.3 Demographic Reach and Achievements
11.12.4 Mergers and Acquisitions
11.12.5 Certifications
12 Philippines Diabetes Care Devices Market - Distribution Model (Additional Insight)
12.1 Overview
12.2 Potential Distributors
12.3 Key Parameters for Distribution Partner Assessment
13 Key Opinion Leaders (KOL) Insights (Additional Insight)
14 Company Competitiveness Analysis (Additional Insight)
14.1 Very Small Companies
14.2 Small Companies
14.3 Mid-Sized Companies
14.4 Large Companies
14.5 Very Large Companies
15 Payment Methods (Additional Insight)
15.1 Government Funded
15.2 Private Insurance
15.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.

Companies Mentioned

  • Becton and Dickenson
  • Medtronic
  • Insulet
  • Tandem
  • Ypsomed
  • Novo Nordisk
  • Sanofi
  • Eli Lilly
  • Abbott
  • Roche
  • Lifescan (Johnson & Johnson)
  • Dexcom

Methodology

Loading
LOADING...